1999-2009 trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Guessous, Idris ^a,b   Bochud, Murielle ^b   Theler, Jean Marc ^a   Gaspoz, Jean Michel ^a   Pechère Bertschi, Antoinette ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; AGING; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; EDUCATIONAL STATUS; FEMALE; GENDER; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBESITY; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SELF REPORT; STANDARDIZATION; SWITZERLAND; SYSTOLIC BLOOD PRESSURE; TREND STUDY;

ADULT; AGED; AWARENESS; HUMANS; HYPERTENSION; INCOME; MIDDLE AGED; PREVALENCE; SWITZERLAND;

EID: 84862988956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039877     Document Type: Article

References (58)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
2. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J, (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens 22: 11-19.
3. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, et al. (1998) Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med 158: 2007-2014.
4. Egan BM, Zhao Y, Axon RN, (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303: 2043-2050.
5. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, et al. (2011) Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 183: 1007-1013.
6. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, et al. (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289: 2363-2369.
7. Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, et al. (2009) Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 16: 66-72.
8. Gaspoz JM, Beer-Borst S, Costanza MC, Morabia A, (2009) Suivi des facteurs de risque cardiovasculaire dans la population genevoise de 1993 à 2007. Available at &http://www.bag.admin.ch/themen/ernaehrung_bewegung/05207/05213/index.html?lang=fr>. Accessed 15 May 2012.
9. European Union Public Health Information System (Euphix). Available at http://www.euphix.org/object_document/o5533n27415.html. Accessed 11 March 2012.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
11. Whitworth JA, (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21: 1983-1992.
12. Bovet P, Romain S, Shamlaye C, Mendis S, Darioli R, et al. (2009) Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles. Cardiovasc Diabetol 8: 34.
13. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, et al. (2008) Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52: 818-827.
14. Tian S, Dong GH, Wang D, Liu MM, Lin Q, et al. (2011) Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertens Res 34: 1087-1092.
15. Muntner P, Gu D, Wu X, Duan X, Wenqi G, et al. (2004) Factors associated with hypertension awareness, treatment, and control in a representative sample of the chinese population. Hypertension 43: 578-585.
16. Agyemang C, van Valkengoed I, Koopmans R, Stronks K, (2006) Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, the Netherlands: the SUNSET study. J Hum Hypertens 20: 874-881.
17. Morabia A, Bernstein M, Heritier S, Ylli A, (1997) Community-based surveillance of cardiovascular risk factors in Geneva: methods, resulting distributions, and comparisons with other populations. Prev Med 26: 311-319.
18. Bernstein M, Sloutskis D, Kumanyika S, Sparti A, Schutz Y, et al. (1998) Data-based approach for developing a physical activity frequency questionnaire. Am J Epidemiol 147: 147-154.
19. Varo JJ, Martinez-Gonzalez MA, De Irala-Estevez J, Kearney J, Gibney M, et al. (2003) Distribution and determinants of sedentary lifestyles in the European Union. Int J Epidemiol 32: 138-146.
20. Bernstein M, Morabia A, Costanza MC, Landis JR, Ross A, et al. (1994) [Nutritional balance of the diet of the adult residents of Geneva]. Soz Praventivmed 39: 333-344.
21. Morabia A, Bernstein M, Kumanyika S, Sorenson A, Mabiala I, et al. (1994) [Development and validation of a semi-quantitative food questionnaire based on a population survey]. Soz Praventivmed 39: 345-369.
22. From the Centers for Disease Control and Prevention (1999) Decline in deaths from heart disease and stroke-United States, 1900-1999. JAMA 282: 724-726.
23. Wagner A, Sadoun A, Dallongeville J, Ferrieres J, Amouyel P, et al. (2011) High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 29: 43-50.
24. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, et al. (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43: 10-17.
25. Efstratopoulos AD, Voyaki SM, Baltas AA, Vratsistas FA, Kirlas DE, et al. (2006) Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 19: 53-60.
26. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, et al. (2005) Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens 23: 1661-1666.
27. Cifkova R, Skodova Z, Lanska V, Adamkova V, Novozamska E, et al. (2004) Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens 18: 571-579.
28. Dorobantu M, Darabont RO, Badila E, Ghiorghe S, (2010) Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study. Int J Hypertens.
29. Galobardes B, Costanza MC, Bernstein MS, Delhumeau CH, Morabia A, (2003) Trends in risk factors for the major "lifestyle-related diseases" in Geneva, Switzerland, 1993-2000. Ann Epidemiol 13: 537-540.
30. Beer-Borst S, Costanza MC, Pechere-Bertschi A, Morabia A, (2009) Twelve-year trends and correlates of dietary salt intakes for the general adult population of Geneva, Switzerland. Eur J Clin Nutr 63: 155-164.
31. Cifkova R, Skodova Z, Lanska V, Adamkova V, Novozamska E, et al. (2004) Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. J Hypertens 22: 1479-1485.
32. Cifkova R, Skodova Z, Bruthans J, Holub J, Adamkova V, et al. (2010) Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens 28: 2196-2203.
33. Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, et al. (2008) Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 178: 1441-1449.
34. Zdrojewski T, Szpakowski P, Bandosz P, Pajak A, Wiecek A, et al. (2004) Arterial hypertension in Poland in 2002. J Hum Hypertens 18: 557-562.
35. Wagner A, Sadoun A, Dallongeville J, Ferrieres J, Amouyel P, et al. (2011) High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 29: 43-50.
36. Bersamin A, Stafford RS, Winkleby MA, (2009) Predictors of hypertension awareness, treatment, and control among Mexican American women and men. J Gen Intern Med 24: 521-527.
37. Brindel P, Hanon O, Dartigues JF, Ritchie K, Lacombe JM, et al. (2006) Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens 24: 51-58.
38. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774.
39. Kannel WB, (1996) Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 275: 1571-1576.
40. Assmann G, Schulte H, (1988) The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116: 1713-1724.
41. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, (1992) Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 268: 3085-3091.
42. Mancia G, Grassi G, (2008) The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines. Ther Adv Cardiovasc Dis 2: 5-12.
43. (1999) World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 17: 151-183.
44. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A, (1997) Blood-pressure control in the hypertensive population. Lancet 349: 454-457.
45. Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M, (2011) The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe. Curr Cardiovasc Risk Rep 5: 174-179.
46. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-181.
47. Mohan S, Campbell NR, (2008) Hypertension management in Canada: good news, but important challenges remain. CMAJ 178: 1458-1460.
48. Ordunez-Garcia P, Munoz JL, Pedraza D, Espinosa-Brito A, Silva LC, et al. (2006) Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens 24: 845-849.
49. Kronborg CN, Hallas J, Jacobsen IA, (2009) Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens 3: 19-24 e12.
50. Falaschetti E, Chaudhury M, Mindell J, Poulter N, (2009) Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 53: 480-486.
51. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, et al. (2009) Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373: 929-940.
52. Whelton PK, He J, Muntner P, (2004) Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 18: 545-551.
53. Wang YR, Alexander GC, Stafford RS, (2007) Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 167: 141-147.
54. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M, (2004) Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 22: 1221-1229.
55. Chen R, Tunstall-Pedoe H, Morrison C, Connaghan J, A'Brook R, (2003) Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited. J Hum Hypertens 17: 751-759.
56. Reinhardt UE, (2004) The Swiss health system: regulated competition without managed care. JAMA 292: 1227-1231.
57. Wolff H, Gaspoz JM, Guessous I, (2011) Health care renunciation for economic reasons in Switzerland. Swiss Med Wkly 141: w13165.
58. OECD Health Data 2011 Available at http://www.oecd.org/document/30/0,3746,en_2649_37407_12968734_1_1_1_37407,00.html Accessed 2012 May 15.